A phase I study of BBI608, a cancer stemness inhibitor, administered with paclitaxel (PTX) as combination therapy (Rx) for pretreated unresectable or recurrent gastric cancer.
2015 ◽
Vol 33
(15_suppl)
◽
pp. e15089-e15089
◽
Keyword(s):
Phase I
◽
2004 ◽
Vol 22
(14_suppl)
◽
pp. 4222-4222
2007 ◽
Vol 37
(12)
◽
pp. 924-929
◽
2004 ◽
Vol 22
(14_suppl)
◽
pp. 4222-4222